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Case Report of Interventional Pulmonology Corner
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Abstract: A 69-year-old woman developed central airway obstruction due to invasive Aspergillus infection
resulting in pseudomembranous tracheobronchitis (PTB). Several challenges were encountered in the
airway management of this patient including her having relatively smaller airways which were more prone
to obstruction by pseudomembranes and made airway interventions difficult. The patient had clinical
deterioration in spite of antifungal therapy and bronchoscopic debridement. The multimodality airway
techniques included the use of smaller biliary balloons for dilatation, using a hybrid stent to slowly dilate and
maintain patency of right main stem and finally the insertion of right secondary carina peripheral Y stent,
which resulted in clinical improvement and allowed time for antifungal therapy to take effect. To the best of
our knowledge, the use of a peripheral Y stent has never been described in the setting of PTB.
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Introduction
Invasive tracheobronchial infection with Aspergillus
is an extremely serious clinical condition with its
pseudomembranous tracheobronchitis (PTB) variant being
the most lethal even after appropriate and timely treatment
with antifungals. Central airway obstruction due to adherent
and extremely hard to remove pseudomembranes adds to the
clinical complexities. We describe a challenging case of PTB
where step-wise multimodality complex airway treatment
played a vital role in achieving desired clinical outcome.
Case presentation
A 69-year-old woman with diffuse large B-cell lymphoma
and Sjogren’s syndrome was hospitalized for recurrent
pneumonias in the setting of neutropenia two months after
completing chemotherapy. She had received six cycles of
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dose adjusted EPOCH (Etoposide, Prednisone, Vincristine,
Cyclophosphamide, Doxorubicin) with Rituximab. The
patient was also on hydrocortisone 10 mg in morning and
5 mg in evening for adrenal insufficiency diagnosed 6 weeks
prior to presentation. CT chest showed consolidation in
bilateral lower lobes and a soft tissue density in the right
main stem bronchus with significant narrowing (Figure 1).
She didn’t improve with multiple courses of antibiotics
including appropriate coverage for Pseudomonas aeruginosa
found in sputum and therefore a flexible bronchoscopy
was requested. The patient had also developed significant
dyspnea by this time and hypoxemia requiring 4 liters of
supplemental oxygen. Flexible bronchoscopy revealed
yellowish thick adherent membranes in the right main stem
with 75% occlusion extending up to bronchus intermedius
(Figure 2A). The areas below the level of obstruction were
severely inflamed with purulent thick secretions. Attempts
to debulk the lesion with Argon Plasma Coagulation (APC)
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and biopsy forceps met with limited success. The patient
was thus intubated with a 10 mm outer diameter (OD)
Bryan-DumonTM rigid bronchoscope (small OD scope was
used as her overall airway size was small) and the stenotic
area was dilated with Controlled radial expansion (CRETM)
pulmonary balloon dilator (Boston Scientific, Natick, MA)
size 8-9-10 mm up to 9 mm (Figure 2B). Debulking with
biopsy forceps (Figure 2C) and balloon dilatation restored

patency to the right main stem (Figure 2D). Biopsies of these
abnormal areas showed significant acute inflammation and
necrosis with fungal organisms consistent with Aspergillus.
A diagnosis of Aspergillus PTB with central airway
obstruction was made and the patient was started on
oral Voriconazole 250 milligram twice a day along with
intravenous immune globulin for hypogammaglobulinemia.
A repeat flexible bronchoscopy was performed 4 weeks
later to reassess the impact of therapy. This revealed
significant worsening of the central airway stenosis with
diffuse yellow thick adherent lesion almost completely
obstructing the right main stem bronchus. This was
extremely challenging as both the therapeutic flexible and
even the pediatric bronchoscopes couldn’t be advanced
through this area of narrowing. Additionally biopsy forceps
was not helpful in achieving any degree of debulking.
Therefore patient was intubated with 10 mm OD BryanDumon TM rigid bronchoscope and some debulking was
performed using a combination of APC, biopsy forceps and
rigid bronchoscope. The stenotic area was initially dilated
with a 5 French Fogarty catheter. Then sequential dilatation
of right main stem was performed with 8 mm OD rigid
bronchoscopes along with a size 8-9-10 CRE pulmonary

Figure 1 Axial CT chest prior to the bronchoscopic interventions,
black arrow showing severe obstruction of the right main stem.
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Figure 2 Sequential images of flexible and rigid bronchoscopy. (A) Aspergillus pseudomembranous tracheobronchitis of the distal trachea
and causing severe obstruction of the right main stem (white arrow); (B) balloon dilation of right main stem; (C) mechanical debulking of the
right main stem obstructive lesion; (D) patent right main stem at the end of the initial bronchoscopic intervention; (E) Severely obstructed
right upper lobe; (F) stenting of the right main stem using the covered metallic stent; (G) the right secondary carina silicone Y stent in place;
(H) patent right upper lobe opening due to right secondary carina silicone Y stent.
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Figure 3 Axial CT chest showing patent right main stem after
removal of the secondary carina Y silicone stent.

balloon catheter. Only the proximal right main stem was
dilated with the 8 mm OD rigid bronchoscope with inability
to advance further distally to the distal right main stem and
bronchus intermedius. The right upper lobe opening was
also 90% occluded (Figure 2E) and was dilated with 5 French
Fogarty catheter. Placement of a peripheral 10-7-7 mm Y
silicone stent customized for the right upper lobe opening
was attempted several times to maintain patency of right
upper lobe along with right main stem with no success due
to significant generalized inflammation causing narrowed
and abnormal angled right upper lobe opening. Finally, the
patient was intubated with a rigid bronchoscope 10 mm OD
and an 8 mm × 15 mm covered metallic (hybrid) AERO stent
(Alveolus, Inc., NC, USA) was placed in the right main stem
(Figure 2F) to maintain patency of the right main stem and
to achieve potential dilatation over time due to the radial
expansive force of the stent. In addition to increasing the
dose of oral Voriconazole to 300 mg twice a day, the patient
was also started on 25 mg of aerosolized Amphotericin B
once a day. The patient remained on her usual regimen of
antihypertensive medications, proton pump inhibitors and
maintenance hydrocortisone.
Flexible bronchoscopy was repeated 2 weeks later. The
patient had again developed worsening of dyspnea. The
right main stem patency was maintained by the stent but the
right upper lobe bronchus had almost completely occluded
with a barely <4 mm opening. The patient was intubated
with 10 mm OD rigid bronchoscope and the AERO stent
was removed. The right main stem bronchus maintained
better luminal patency as compared to that observed during
the previous bronchoscopy likely due to the AERO stent.
The right upper lobe opening was sequentially dilated to
8 mm using a 2 mm × 6 mm biliary balloon, a 7 French
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Fogarty catheter, and a 2 mm × 8 mm biliary balloon
respectively. The right main stem and bronchus intermedius
were dilated to 10 mm using an 8-9-10 mm CRETM balloon.
A customized 10-7-7 mm Y silicone stent (Lengths: right main
stem—15 mm, bronchus intermedius—5 mm and right upper
lobe—5 mm) without studs (Hood Laboratories, Pembroke,
MA) was then successfully deployed as the right main stem
was more patent and allowed us to overcome the technical
difficulties that we encountered earlier (Figure 2G,H).
The patients’ symptoms improved significantly after
placement of the peripheral Y stent. Follow up CT showed
patent airways (Figure 3) and surveillance bronchoscopies
performed at monthly intervals twice did not show
any evidence of recurrent central airway stenosis. The
peripheral Y stent was removed after one year without any
evidence of abnormal infected mucosa underneath and the
pseudomembranes had completely resolved. The right-sided
involved airway had developed fibrosis and some stenosis
but still maintained its patency at approximately 70% of the
original size (Figure 4) and this was also noted on subsequent
CT of the chest (Figure 3). The patient completed one year
of oral Voriconazole therapy and remained asymptomatic
with good performance status without any further clinical
deterioration or recurrence of infection.
Discussion
Aspergillus is a ubiquitous fungus and the aerosolized
spores frequently get inhaled and get deposited in the
human airways. In healthy people, innate immunological
and mucociliary defenses effectively eliminate the spores.
However invasive aspergillosis can be seen in people
with defective immunity like those with neutropenia,
hematological malignancies, organ transplant, diabetes
mellitus, long-term corticosteroid use etc. Similarly this
condition can also be encountered in those with structural
lung disease and defective mucociliary mechanism like those
with chronic obstructive lung disease and sarcoidosis (1).
A small fraction of patient (approximately 10%) with
invasive aspergillosis may be immunocompetent. Aspergillus
can cause invasive tracheobronchial disease, which
ultimately requires a bronchoscopy for diagnosis and
tracheobronchial invasive involvement is subcategorized into
ulcerative, obstructive and pseudomembranous variants (1).
Pseudomembrane tracheobronchitis (PTB) is caused by
invasion of tracheobronchial mucosa by aspergillus with
necrosis and sloughing off of tissue into airway and is the
variant with the most aggressive clinical course and a high
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Figure 4 Bronchoscopy after removal of right secondary carina silicone Y stent. (A) Right main stem patent with some residual narrowing
and fibrosis; (B) right upper lobe opening is patent with some granulation tissue related to the stent.

fatality rate in spite of treatment and irrespective of immune
status of the patient (2-4). Currently there is no system
of classification of severity of PTB but literature suggests
that the subgroup the patients who require mechanical
ventilation have the lowest chance of survival (3,4). As the
obstructing pseudomembranes may be responsible for
poor antifungal penetration and also for development of
respiratory failure, therefore maintaining the patency of the
central airway to prevent progressive respiratory failure and
allowing more time for the antifungal medications to work
may be an extremely critical factor in such patients.
Our case demonstrates several complexities of management
of central airway obstruction of the patients with PTB.
First of all, our patients had genetically smaller airways
making them more prone to be completely obstructed
with tissue debris and we had to use relatively smaller rigid
bronchoscope and smaller balloons to dilate the airway
including the use of Fogarty catheters and biliary balloons.
Understanding the utility of accessories available with our
gastroenterology colleagues was helpful. Secondly the
difficulty in removal of extensive thick and sticky obstructive
debris is well described. Even thermal techniques like
APC, electrocautery, laser and cryotherapy may not work
well as seen in this case although combination with rigid
bronchoscopic debulking was helpful. Thirdly, extreme
caution needs to be exercised when removing these
membranes as patient death has been reported from massive
pulmonary artery bleed during removal of obstructive
infective tissue (5). Careful review of CT imaging may
be of some help to know the relationship of involved
airway with major blood vessels and to assess the risk of
major bleeding. Additional imaging modalities like CT
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pulmonary angiography, digital subtraction angiography
and endobronchial ultrasound or interventions like
embolization prior to bronchoscopic procedures in high
risk cases may be helpful but have not been well described
in literature. We cautiously removed some debris to obtain
the patency of right main stem and placed an AERO hybrid
stent to slowly dilate the right main stem over several days,
as we were not able to initially place a peripheral Y stent,
which could have allowed us to maintain the patency of
right upper lobe. Fourthly, there is limited literature on
the appropriate selection of airway stents for PTB. The
deployment of metallic or hybrid airway stent has been
reported in post-transplant tracheobronchial stump stenosis
due to aspergillus infection (2,6). The use of silicone stents
has been described only on rare occasions in the setting of
Aspergillus tracheobronchial infection including one case
for airway stenosis after treatment of bronchomediastinal
fistula and another for post-tuberculosis tracheal stricture
with superimposed PTB (7,8). Finally, the issue of placing
an airway stent in the setting of infection is a subject of
debate (8). Pornsuriyasak et al. described a case of PTB
superimposed on post-tubercular tracheal stricture. They
dilated the trachea with rigid bronchoscope and avoided
placing a stent in the setting of acute infection. The patient
showed clinical improvement flexible bronchoscopy a week
later showed improved pseudomembranes. The patient
developed recurrent tracheal stricture in the absence
of PTB and a silicone stent was placed. In our case, the
patient likely had more severe and more extensive PTB
and there was clinical deterioration in spite of appropriate
antifungal therapy and there was no choice but to place a
stent to prevent further worsening of respiratory status.
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The obstructive exudates still progressed and obstructed the
right upper lobe with clinical deterioration but the hybrid
stent kept the right main stem bronchus patent. This also
possibly allowed us to achieve some slow right main stem
dilatation and finally placement of a peripheral silicone Y
stent. Finally, to the best of our knowledge, a peripheral Y
stent has never been placed in the setting of PTB and was
an additional unique and challenging aspect of this case.
The techniques of peripheral Y stents have been described
previously (9,10) but usual anatomical factors can pose
significant challenges in deployment (11). We were able to
successfully deploy a peripheral Y stent even in the setting
of diffuse airway obstruction by PTB. This was not only
associated with immediate clinical improvement but also
allowed the antifungal therapy to take effect thus allowing
our patient a better chance at survival.
In summary, we describe the challenges faced in the
complex multimodality management of central airway
obstruction of a patient with PTB. We believe that
thoughtful, cautious and determined airway management
may help in slowing the clinical deterioration of this
aggressive airway infection, which may offer a chance of
improved survival to some patients.
Acknowledgements
None.
Footnote
Conflicts of Interest: The authors have no conflicts of interest
to declare.
Informed Consent: Written informed consent was obtained
from the patient for publication of this manuscript and any

919

accompanying images.
References
1.

Patterson KC, Strek ME. Diagnosis and treatment of
pulmonary aspergillosis syndromes. Chest 2014;146:1358-68.
2. Karnak D, Avery RK, Gildea TR, et al. Endobronchial
fungal disease: an under-recognized entity. Respiration
2007;74:88-104.
3. Li Y, Yu F, Parsons C, et al. Pseudomembranous Aspergillus
tracheobronchitis: a potential for high mortality in low-risk
patients. Am J Med Sci 2013;346:366-70.
4. Tasci S, Glasmacher A, Lentini S, et al. Pseudomembranous
and obstructive Aspergillus tracheobronchitis - optimal
diagnostic strategy and outcome. Mycoses 2006;49:37-42.
5. Putnam JB Jr, Dignani C, Mehra RC, et al. Acute airway
obstruction and necrotizing tracheobronchitis from
invasive mycosis. Chest 1994;106:1265-7.
6. Xie BX, Zhu YM, Chen C, et al. Outcome of TiNi
stent treatments in symptomatic central airway stenoses
caused by Aspergillus fumigatus infections after lung
transplantation. Transplant Proc 2013;45:2366-70.
7. Argento AC, Wolfe CR, Wahidi MM, et al.
Bronchomediastinal fistula caused by endobronchial
aspergilloma. Ann Am Thorac Soc 2015;12:91-5.
8. Pornsuriyasak P, Murgu S, Colt H. Pseudomembranous
aspergillus tracheobronchitis superimposed on posttuberculosis tracheal stenosis. Respirology 2009;14:144-7.
9. Oki M, Saka H, Kitagawa C, et al. Silicone y-stent
placement on the carina between bronchus to the right
upper lobe and bronchus intermedius. Ann Thorac Surg
2009;87:971-4.
10. Oki M, Saka H. Silicone Y-Stent Placement on the
Secondary Left Carina. Respiration 2015;90:493-8.
11. Harris K, Dhillon SS, Alraiyes AH. Personalized bronchial
stent therapy. Ann Am Thorac Soc 2015;12:451-4.

Cite this article as: Dhillon SS, Saoud M, Harris K. Complex
multimodality central airway management of aspergillus
pseudomembranous tracheobronchitis. J Thorac Dis
2017;9(4):915-919. doi: 10.21037/jtd.2017.03.68

© Journal of Thoracic Disease. All rights reserved.

jtd.amegroups.com

J Thorac Dis 2017;9(4):915-919

